Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma

Amir Amirabadi; Amirhosein Alami; Hamid Ahanchian; Nazila Ariaee; Nasrin Moazzen

doi:10.1002/ccr3.4021

Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma

Clin Case Rep. 2021 Mar 24;9(5):e04021. doi: 10.1002/ccr3.4021. eCollection 2021 May.

Authors

Amir Amirabadi¹, Amirhosein Alami², Hamid Ahanchian^{3

4}, Nazila Ariaee³, Nasrin Moazzen^{3

4}

Affiliations

¹ Department of Internal Medicine Azad University of Medical Sciences Mashhad Iran.
² Department of Biology Azad University of Medical Sciences Mashhad Iran.
³ Clinical Research Development Unit of Akbar hospital Mashhad University of medical Sciences Mashhad Iran.
⁴ Allergy Research Center Mashhad University of Medical Sciences Mashhad Iran.

Abstract

Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.

Keywords: Basal cell carcinoma; cetuximab; epidermal growth factor receptor inhibitor; skin cancer.

Publication types

Case Reports